Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Smoking Cessation 1 Sarcoma 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1 Depression 1 Central Nervous System Neoplasms 1 Anxiety Disorders 1 Alzheimer Disease 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 161 Fluorouracil 135 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 88 Carboplatin 72 Docetaxel 71 Irinotecan 60 pembrolizumab 57 Leucovorin 57 Capecitabine 57 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 42 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Amyloid × Clear all

NCT02530983 2026-03-30

UDD

Mayo Clinic

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡